https://orcid.org/0000-0002-6860-8050
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Brian Godman, Mainul Haque, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Eleonora Allocati, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Jitendra Acharya, Takuma Sugahara, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Alice Pisana, Janney Wale & Mihajlo Jakovljevic. (2021) Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future. Current Medical Research and Opinion 37:9, pages 1529-1545.
Read now
Read now
Articles from other publishers (4)
Kuan Peng, Joseph E. Blais, Nicole L. Pratt, Jeff Jianfei Guo, Jodie B. Hillen, Tyman Stanford, Michael Ward, Edward Chia-Cheng Lai, Ju-Young Shin, Xinning Tong, Min Fan, Franco W. T. Cheng, Jing Wu, Winnie W. Y. Yeung, Chak-Sing Lau, Wai Keung Leung, Ian C. K. Wong & Xue Li. (2023) Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis. BioDrugs 37:3, pages 409-420.
Crossref
Crossref
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian & Mahmoud Zureik. (2022) TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System. Scientific Reports 12:1.
Crossref
Crossref
Yoshiko Aoki, Kimie Sai, Yukiko Katsuta, Mika Suzuki, Yasuo Suzuki, Akiko Ishii-Watabe & Yoshiro Saito. (2022) Questionnaire Survey on Adoption and Prescription of Biosimilars (Antibody and Its-related Products) by Medical Doctors in Japan本邦における抗体及び抗体関連医薬品のバイオシミラー採用及び処方に関する医師の意識調査. YAKUGAKU ZASSHI 142:5, pages 547-560.
Crossref
Crossref
Takashi Eto, Yuji Karasuyama, Verónica González & Ana Del Campo García. (2021) A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers. Cancer Chemotherapy and Pharmacology 88:4, pages 713-722.
Crossref
Crossref